Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The effect of early supplemental parental nutrition in patients after pancreaticoduodenectomy

View through CrossRef
Abstract Background/OBJECTIVES: Pancreaticoduodenectomy (PD) has multi-potential factors for malnutrition as its surgical boundary covers organs with digestive juices. The utility of supplemental parental nutrition (PN) is controversial for patients underwent PD. This study aimed to investigate clinical effect of using routine supplemental-PN after PD.SUBJECTS/Methods: From 2014 to 2020, 927 patients undergoing PD in Samsung Medical Center were divided into two groups, those who used routine supplemental-PN (n = 161) and those who did not (n = 766) and analyzed retrospectively. The routine supplemental-PN was administered to patients by using PN with oral feeding together, started after immediate postoperative 1–3 days without interruption. A subgroup analysis was performed for patients with diabetes mellitus (DM) and sarcopenia.Results Regarding postoperative complications, the supplemental-PN group had significantly higher rates of postoperative pancreatic fistula (POPF) (p < 0.001) and delayed gastric emptying (p = 0.012) than the non-PN group. The supplemental-PN group had similar hospital stay to the non-PN group (p = 0.547). In subgroup analysis for those with DM (n = 252), the supplemental-PN group had significantly higher postoperative major complications (37.5 vs. 20.6%, p = 0.016), especially POPF (27.1 vs. 10.8%, p = 0.006), than the non-PN group. For sarcopenic patients (n = 89), the supplemental-PN group had significantly longer hospital stay than the non-PN group (13.7 days vs. 11.4 days, p = 0.040).Conclusion In terms of postoperative complications, routine use of supplemental-PN after PD is not beneficial for patients. Especially with DM and sarcopenia, its use needs caution.
Title: The effect of early supplemental parental nutrition in patients after pancreaticoduodenectomy
Description:
Abstract Background/OBJECTIVES: Pancreaticoduodenectomy (PD) has multi-potential factors for malnutrition as its surgical boundary covers organs with digestive juices.
The utility of supplemental parental nutrition (PN) is controversial for patients underwent PD.
This study aimed to investigate clinical effect of using routine supplemental-PN after PD.
SUBJECTS/Methods: From 2014 to 2020, 927 patients undergoing PD in Samsung Medical Center were divided into two groups, those who used routine supplemental-PN (n = 161) and those who did not (n = 766) and analyzed retrospectively.
The routine supplemental-PN was administered to patients by using PN with oral feeding together, started after immediate postoperative 1–3 days without interruption.
A subgroup analysis was performed for patients with diabetes mellitus (DM) and sarcopenia.
Results Regarding postoperative complications, the supplemental-PN group had significantly higher rates of postoperative pancreatic fistula (POPF) (p < 0.
001) and delayed gastric emptying (p = 0.
012) than the non-PN group.
The supplemental-PN group had similar hospital stay to the non-PN group (p = 0.
547).
In subgroup analysis for those with DM (n = 252), the supplemental-PN group had significantly higher postoperative major complications (37.
5 vs.
20.
6%, p = 0.
016), especially POPF (27.
1 vs.
10.
8%, p = 0.
006), than the non-PN group.
For sarcopenic patients (n = 89), the supplemental-PN group had significantly longer hospital stay than the non-PN group (13.
7 days vs.
11.
4 days, p = 0.
040).
Conclusion In terms of postoperative complications, routine use of supplemental-PN after PD is not beneficial for patients.
Especially with DM and sarcopenia, its use needs caution.

Related Results

Supplementary figures S1-S18 from Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma
Supplementary figures S1-S18 from Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma
<p>Supplemental figures Supplemental Fig. 1. TRIM29 is highly expressed in stratified epithelial tissues. Supplemental Fig. 2. The expression levels of TRIM29 protein are as ...
Supplementary figures S1-S18 from Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma
Supplementary figures S1-S18 from Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma
<p>Supplemental figures Supplemental Fig. 1. TRIM29 is highly expressed in stratified epithelial tissues. Supplemental Fig. 2. The expression levels of TRIM29 protein are as ...
Supplemental Figures from GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity
Supplemental Figures from GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity
<p>Supplemental Figure 1. GPS and Physical Activity Data Overlaid on a. Greenness and b. Neighborhood Walkability. Supplemental Figure 2. Nonlinear Relationship between Activ...
Supplemental Figures from GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity
Supplemental Figures from GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity
<p>Supplemental Figure 1. GPS and Physical Activity Data Overlaid on a. Greenness and b. Neighborhood Walkability. Supplemental Figure 2. Nonlinear Relationship between Activ...
Safety and hazards of middle-life robotic pancreaticoduodenectomy
Safety and hazards of middle-life robotic pancreaticoduodenectomy
Abstract Pancreaticoduodenectomy procedures were performed early in young individuals, with a few days about the risk and survival after robotic pancreaticoduodenectomy. Ou...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top